The research for finding new cancer agents with good efficacy and low toxicity is still in demand because this disease is still counted as main cause of death worldwide. Chalcone derivatives are known as prospective sources to find potent anticancer agent. Some amino chalcone and coumarin chalcone derivatives have been successfully synthesized from the reaction of 4’-amino acetophenone, acetyl coumarin, and derivatives of benzaldehyde by Claisen-Schmidt reaction. The molecular structure of the prepared compounds was determined by spectroscopic evidence including IR, ESIMS, 1H- and 13C-NMR. Anti-proliferative activity of the prepared compounds is examined using MTT reagent. Apoptosis and cell cycle inhibition were determined by the flow cytometer. Double staining using orange acridine – etidium bromide was used to determine morphologically cancer cells underwent apoptosis. The IC50 value of anti-proliferative examination ranging from 30.4 µg/mL to more than 100 µg/mL toward T47D cells and from 27.5 µg/mL to more than 100 µg/mL toward HeLa cells. Compound 2 (E)-1-(4-aminophenyl)-3-(4-fluoro-phenyl)prop-2-en-1-one exhibited the most active anticancer activity through induction apoptosis mechanism. It caused cell cycle arrest at G0/G1 and G2/M phase both for HeLa cells and T47D cells. Additionally, it also blocks S phase for T47D cells.

1.
World Health Organization
, WHO – Cancer reports, http://www.who.int/gho/en/, accessed 9 October 2018.
2.
M. L.
Go
,
X.
Wu
,
X. L.
Liu
,
Curr. Med. Chem
12
,
483
499
(
2005
).
3.
H.
Suwito
,
J.
Jumina
,
M.
Mustofa
,
N.
Ni’matuzahroh
,
N. N. T.
Puspaningsih
,
Der Pharma Chemica
7
,
89
94
(
2015
)
4.
A.
Novila
,
I.
Astuti
,
J.
Jumina
,
H.
Suwito
,
J. Med. Scie.
49
,
153
164
(
2017
).
5.
A.
Novila
,
M.
Mustofa
,
I.
Astuti
,
J.
Jumina
,
H.
Suwito
,
Bioscie. Res.
14
,
731
740
(
2017
).
6.
I. A. I.
Wahyuniarti
,
I. G. K. N.
Arijina
,
N. P.
Sriwidyani
,
I. A. D.
Wiryanthini
,
H.
Suwito
,
S.
Widryani
,
M.
Gufron
,
M.
Mustofa
,
S.
Mubarika
, S.,
Bali Med. J.
6
,
589
594
(
2017
).
7.
Z.
Rozmer
,
T.
Berki
,
P.
Perjési
,
Toxicol. In Vitro
20
,
1354
1362
(
2006
).
8.
S. F.
Nielsen
,
T.
Boesen
,
M.
Larsen
,
K.
Schonning
,
H.
Kromann
, H.,
Bioorg. Med. Chem.
12
,
3047
3054
(
2004
).
9.
H.
Suwito
,
N.
Ni’matuzahroh
,
A.N.
Kristanti
, A.N.,
S.
Hayati
,
S. D.
Dewi
,
I.
Amalina
, I.,
N. N. T.
Puspaningsih
,
Proc. Chem.
18
,
103
111
(
2016
).
10.
K. L.
Lahtchev
,
D. I.
Batovska
,
S. P.
Parushev
,
V. M.
Ubiyvovk
,
A. A.
Sibirny
,
Eur. J. Med. Chem
43
,
2220
2228
(
2008
).
11.
J. H.
Wu
,
X. H.
Wang
,
Y. H.
Yi
,
K. H.
Lee
,
Bioorg. Med. Chem. Lett.
13
,
1813
1815
(
2003
).
12.
C.
Zhan
,
J.
Yang
, J.,
Pharmacol. Res.
53
,
303
309
(
2006
).
13.
M.
Liu
,
P.
Wilairat
,
M. L.
Go
,
2001
,
J. Med. Chem.
44
,
444
4452
(
2001
).
14.
H.
Suwito
,
J.
Jumina
,
M.
Mustofa
,
P.
Pudjiastuti
,
M. Z.
Fanani
,
Y.
Kimata-Ariga
,
R.
Katahira
,
T.
Kawakami
,
T.
Fujiwara
,
T.
Hase
,
H. M.
Sirat
,
N. N. T.
Puspaningsih
,
Molecules
19
,
21473
21488
(
2014
).
15.
E. B.
Yang
,
Y. J.
Guo
,
K.
Zhang
, K.,
Y.Z.
Chen
,
P.
Mack
, P.,
Biochemica et Biophysica Acta
1550
,
144
152
(
2001
).
16.
E.
Hofmann
,
J.
Webster
,
T.
Do
,
R.
Kline
,
L.
Snider
,
Q.
Hauser
,
G.
Higginbottom
,
A.
Campbell
,
L.
Ma
,
S.
Paula
,
Bioorg Med Chem.
24
,
578
587
(
2016
).
17.
B. T.
Kim
, K-J. O, K-J.,
J-C
,
Chun
, K-J,
K-J.
Hwang
,
Bull. Korean. Chem. Soc.
29
, pp.
1125
1130
(
2008
).
18.
C.
Viegas-Junior
,
A.
Danuello
,
V. S.
Bolzani
,
E. J.
Barreiro
,
C. A. M.
Fraga
,
Curr. Med. Chem.
14
,
1829
1852
(
2007
).
19.
U.
Fischer
,
K.
Schulze-Osthoff
,
Pharmacol. Rev.
57
,
187
215
(
2005
).
20.
A.
Link
,
F.
Balaguer
,
A.
Goel
,
Biochem. Pharmacol.
80
,
1771
1792
(
2010
).
21.
S.
Zhang
,
T.
Li
,
L.
Zhang
,
X.
Wang
,
H.
Dong
,
L.
Li
,
D.
Fu
,
Y.
Li
,
X.
Zi.
,
H.
Liu
,
Y.
Zhang
,
H.
Xu
,
C-Y
Jin
,
C-
Y.
,
Scientific Reports
,
7
(
9873
),
1
13
(
2017
).
22.
CCRC
,
Prosedur Tetap Uji Sitotoksik Metode MTT
(
Gadjah Mada Press
,
Yogyakarta
,
2014
),
20
30
.
This content is only available via PDF.
You do not currently have access to this content.